Related Experiment Video
Updated: Jun 17, 2026

04:36
Implantation Protocol of the Foldable Capsular Vitreous Body for Complex Vitreoretinal Surgery
Published on: April 14, 2026
One-Month versus 3-Month Heavy Silicone Oil Tamponade in Complex Rhegmatogenous Retinal Redetachment
Giancarlo Sborgia1, Giacomo Boscia1, Alfredo Niro2
1Department of Translational Biomedicine and Neuroscience, Eye Clinic, University of Bari, Bari, Italy.
Summary
A 1-month heavy silicone oil (HSO) tamponade shows similar re-attachment rates for recurrent retinal detachment but offers better visual outcomes and IOP control compared to a 3-month HSO duration.
Area of Science:
- Ophthalmology
- Retinal Surgery
- Vitreoretinal Interface
Background:
- Complex inferior rhegmatogenous retinal detachment recurrence (Re-RRD) poses significant surgical challenges.
- Heavy silicone oil (HSO) is utilized for tamponade in challenging retinal detachment cases.
Purpose of the Study:
- To compare functional and anatomical outcomes of 1-month versus 3-month HSO tamponade for complex inferior Re-RRD.
- Evaluate the impact of HSO duration on re-attachment rates, visual acuity, and intraocular pressure.
Main Methods:
- Retrospective comparative cohort study of 46 eyes with complex inferior Re-RRD previously treated with gas or silicone oil.
- Eyes were treated with HSO (DENSIRON®68) removed after 1 month (Group A) or 3 months (Group B).
- Outcomes assessed included re-attachment rate, best-corrected visual acuity (BCVA), and intraocular pressure (IOP) at 3, 6, and 12 months post-removal.
Main Results:
- Similar re-attachment rates between Group A (91.6%) and Group B (81.8%).
- Group A demonstrated significantly better BCVA at 6 and 12 months post-removal.
- Group B showed a significant increase in IOP post-HSO removal, consistently higher than Group A.
Conclusions:
- A 1-month HSO tamponade achieves comparable re-attachment rates to a 3-month duration for complex inferior Re-RRD.
- Shorter HSO tamponade (1 month) leads to superior visual recovery and better intraocular pressure management.

